The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...
In a longitudinal cohort study, patients with multiple sclerosis underwent cognitive evaluation and magnetic resonance imaging scans at baseline and after 3 years. Memory decline was observed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback